HCAP Partners, a California-based private equity firm, invested in DFW Neuropathy, a neuropathy treatment company based in North Texas that specializes in Combination Electroanalgesia Treatment to heal or reverse peripheral neuropathy. Terms of the investment were not disclosed.
Baymark Partners, a Dallas-based private equity firm, led the transaction.
DFW Neuropathy is a growing neuropathy treatment company with four locations in the Dallas–Fort Worth metroplex.
HCAP Partners was founded in 2000 and is a provider of mezzanine debt and private equity for underserved, lower-middle market companies throughout California and the Western United States. The firm seeks to invest $3 million to $25 million in established businesses generating between $10 million and $100 million in revenues in the healthcare, software, services, and manufacturing industries. Read more.
